Ajanta Pharma Q1FY24 Results: Consolidated PAT of Rs. 208.12 Cr
Ajanta Pharma Q1 results show revenue up from 918.67 crores to 1,052.79 crores, a 14.60% increase in growth. EPS rise…
Ajanta Pharma Share Price
Read More
Ajanta Pharma: US FDA Clears Dahej Facility for Operations
Ajanta Pharma Receives US FDA Clearance for Dahej Facility Ajanta Pharma, a prominent pharmaceutical company, has recently obtained clearance from…